Published in Breast Cancer Weekly, April 8th, 2000
The patent claims granted are for the nontoxic induction of apoptosis. Many present methods of cancer therapy, such as radiation treatment and tamoxifen, kill cancer cells by inducing apoptosis, also known as cell suicide and programmed cell death, but these methods are toxic to the patient.
The Infectech method induces apoptosis in a completely novel and nontoxic manner by changing the microcytoarchitecture of cancer cells by using hydrophobic hydrocarbons. Thomas A. Kelly, PhD, Infectech, Inc., published this method in the May 1999 issue of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Breast Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.